Cargando…

Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer’s disease

Alzheimer’s disease (AD) is a debilitating neurodegenerative disease characterized by declining cognition and behavioral impairment, and hallmarked by extracellular amyloid-β plaques, intracellular neurofibrillary tangles (NFT), oxidative stress, neuroinflammation, and neurodegeneration. There is cu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coles, Madilyn, Steiner-Lim, Genevieve Z., Karl, Tim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9479694/ https://www.ncbi.nlm.nih.gov/pubmed/36117622 http://dx.doi.org/10.3389/fnins.2022.962922

Ejemplares similares

Medium-Dose Chronic Cannabidiol Treatment Reverses Object Recognition Memory Deficits of APP (Swe) /PS1ΔE9 Transgenic Female Mice
por: Coles, Madilyn, et al.
Publicado: (2020)

Impact of the Cannabinoid System in Alzheimer's Disease
por: Li, Shuangtao, et al.
Publicado: (2023)

TLR4 Targeting as a Promising Therapeutic Strategy for Alzheimer Disease Treatment
por: Zhou, Yongji, et al.
Publicado: (2020)

Multi-Targets: An Unconventional Drug Development Strategy for Alzheimer’s Disease
por: Gong, Cheng-Xin, et al.
Publicado: (2022)

Editorial: Cannabinoids as potential treatment for neurological diseases
por: Gómez-Cañas, María, et al.
Publicado: (2022)

Cannabinoid pharmacology and its therapeutic uses in Alzheimer’s disease
por: Monteiro, Kadja Luana Chagas, et al.
Publicado: (2020)

Targeting the cannabinoid system to counteract the deleterious effects of stress in Alzheimer’s disease
por: Shade, Ronnie D., et al.
Publicado: (2022)

Targeting TNFR2 as a Novel Therapeutic Strategy for Alzheimer’s Disease
por: Ortí-Casañ, Natalia, et al.
Publicado: (2019)

Cannabinoids in Chronic Pain: Therapeutic Potential Through Microglia Modulation
por: van den Hoogen, Nynke J., et al.
Publicado: (2022)

Targeting Beta-Amyloid at the CSF: A New Therapeutic Strategy in Alzheimer’s Disease
por: Menendez-Gonzalez, Manuel, et al.
Publicado: (2018)

Current and future therapeutic strategies for Alzheimer’s disease: an overview of drug development bottlenecks
por: Peng, Yong, et al.
Publicado: (2023)

In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease
por: Watt, Georgia, et al.
Publicado: (2017)

Cannabinoid signaling and risk in Huntington's disease
por: Humble, James, et al.
Publicado: (2022)

Mesenchymal stromal cells for the treatment of Alzheimer’s disease: Strategies and limitations
por: Regmi, Shobha, et al.
Publicado: (2022)

Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic
por: Aso, Ester, et al.
Publicado: (2014)

Vascular Dysfunction in a Transgenic Model of Alzheimer's Disease: Effects of CB1R and CB2R Cannabinoid Agonists
por: Navarro-Dorado, Jorge, et al.
Publicado: (2016)

Evaluation of cannabinoid type 2 receptor expression and pyridine-based radiotracers in brains from a mouse model of Alzheimer’s disease
por: Kecheliev, Vasil, et al.
Publicado: (2022)

Cannabinoids, Endocannabinoids and Sleep
por: Kesner, Andrew J., et al.
Publicado: (2020)

Editorial: Experimental and Innovative Approaches to Multi-Target Treatment of Parkinson's and Alzheimer's Diseases
por: Tikhonova, Maria A., et al.
Publicado: (2022)

From Cannabinoids and Neurosteroids to Statins and the Ketogenic Diet: New Therapeutic Avenues in Rett Syndrome?
por: Mouro, Francisco Melo, et al.
Publicado: (2019)

Exploiting the Multifaceted Effects of Cannabinoids on Mood to Boost Their Therapeutic Use Against Anxiety and Depression
por: Stampanoni Bassi, Mario, et al.
Publicado: (2018)

Editorial: The CB2 Cannabinoid System: A New Strategy in Neurodegenerative Disorder and Neuroinflammation
por: Contino, Marialessandra, et al.
Publicado: (2017)

Roles of the Cannabinoid System in the Basal Ganglia in Parkinson’s Disease
por: Wang, Mengya, et al.
Publicado: (2022)

Taking Advantage of the Selectivity of Histone Deacetylases and Phosphodiesterase Inhibitors to Design Better Therapeutic Strategies to Treat Alzheimer’s Disease
por: Cuadrado-Tejedor, Mar, et al.
Publicado: (2019)

Nanoliposomes as a Therapeutic Tool for Alzheimer’s Disease
por: Ordóñez-Gutiérrez, Lara, et al.
Publicado: (2020)

Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target
por: Cassano, Tommaso, et al.
Publicado: (2017)

Cannabinoid Modulation of the Stressed Hippocampus
por: Scarante, Franciele F., et al.
Publicado: (2017)

Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease
por: Kendall, Debra A., et al.
Publicado: (2017)

Potential and Limits of Cannabinoids in Alzheimer’s Disease Therapy
por: Abate, Giulia, et al.
Publicado: (2021)

Amyloid-β Peptide Impact on Synaptic Function and Neuroepigenetic Gene Control Reveal New Therapeutic Strategies for Alzheimer’s Disease
por: Karisetty, Bhanu Chandra, et al.
Publicado: (2020)

Modulation of the Cannabinoid System: A New Perspective for the Treatment of the Alzheimer’s Disease
por: Giuseppina, Talarico, et al.
Publicado: (2019)

Editorial: Experimental and innovative approaches to multi-target treatment of Parkinson's and Alzheimer's diseases - Volume II
por: Tikhonova, Maria A., et al.
Publicado: (2023)

NSAIDs: How they Work and their Prospects as Therapeutics in Alzheimer's Disease
por: Sastre, Magdalena, et al.
Publicado: (2010)

Fluid Biomarkers in Clinical Trials of Alzheimer’s Disease Therapeutics
por: Ritter, Aaron, et al.
Publicado: (2015)

The Contribution and Therapeutic Potential of Epigenetic Modifications in Alzheimer’s Disease
por: Wood, Ian C.
Publicado: (2018)

Iron and Alzheimer’s Disease: From Pathogenesis to Therapeutic Implications
por: Liu, Jun-Lin, et al.
Publicado: (2018)

Gamma Oscillations in Alzheimer’s Disease and Their Potential Therapeutic Role
por: Traikapi, Artemis, et al.
Publicado: (2021)

Pyroptosis as a candidate therapeutic target for Alzheimer’s disease
por: Huang, Yuehua, et al.
Publicado: (2022)

Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials
por: Miao, Jifei, et al.
Publicado: (2023)

An update on the use of gamma (multi)sensory stimulation for Alzheimer’s disease treatment
por: Manippa, Valerio, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lmimut4118i4lb8uk7ttmdfe25